InsiderTrades

Form 4 for DAL Delta Air Lines

Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0001683168-22-000892 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-02-11 2022-02-09 DAL Ausband Allison C EVP-Chief Cust Experience Offr A - Grant — +7,840 39.1K +25% —
D 2022-02-11 2022-02-09 DAL Ausband Allison C EVP-Chief Cust Experience Offr F - Tax $43.88 -2,872 36.2K -7% -$126.0K
D 2022-02-11 2022-02-09 DAL Ausband Allison C EVP-Chief Cust Experience Offr A - Grant $0.00 +10.8K 10.8K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-09 A A 7,840 — 39,096 D — — (F1) Settlement of performance awards granted under Delta's 2019 long-term incentive program which were earned effective February 9, 2022. The grant of the performance awards was approved by the Personnel & Compensation Committee of Delta's Board of Directors (the "Committee") and is exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3(d)(1).
2 Common Common Stock 2022-02-09 F D 2,872 $43.88 36,224 D — — (F2) Shares withheld for payment of tax liability upon settlement of the performance awards earned under Delta's 2019 long-term incentive program. This withholding was approved by the Committee and is exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rules 16b-3(d)(1) and 16b-3(e).
3 Derivative Employee Stock Option (right to buy) 2022-02-09 A A 10,770 $0.00 10,770 D $58.89 · 2022-02-09 to 2030-02-04 10,770 Common Stock (F3) On February 5, 2020, the Committee granted Ms. Ausband an option to purchase 10,770 shares of common stock. The option vests based on Delta's satisfaction of certain performance criteria. The performance criteria was certified by the Committee on February 9, 2022. Because the performance criteria were met, the option as to 7,180 shares vested, and the option for the remaining 3,590 shares will vest on February 1, 2023. This grant was approved by the Committee and is exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3(d).